Inside Life Sciences

UK Government considers legislative exemption for CBD consumer products

The Government has revealed that it is considering introducing a new exemption for cannabidiol (CBD) consumer products under the Misuse of Drugs Regulations 2001.

The Medicines and Medical Devices Act 2021: A framework for updating the UK life sciences regime

The Medicines and Medical Devices Act 2021 (MMDA) received Royal Assent on 11 February 2021. The context for the MMDA is that much of the legal and regulatory framework for medicines and medical devices derives from EU Directives.